Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Adiponectin-mediated modulation of lymphatic vessel formation and lymphedema.

Identifieur interne : 001C65 ( PubMed/Checkpoint ); précédent : 001C64; suivant : 001C66

Adiponectin-mediated modulation of lymphatic vessel formation and lymphedema.

Auteurs : Yuuki Shimizu [Japon] ; Rei Shibata ; Masakazu Ishii ; Koji Ohashi ; Takahiro Kambara ; Yusuke Uemura ; Daisuke Yuasa ; Yoshiyuki Kataoka ; Shinji Kihara ; Toyoaki Murohara ; Noriyuki Ouchi

Source :

RBID : pubmed:24052499

Descripteurs français

English descriptors

Abstract

Obesity is linked with an increased risk of lymphedema, which is a serious clinical problem. Adiponectin is a circulating adipokine that is down-regulated in obese states. We investigated the effects of adiponectin on lymphatic vessel formation in a model of lymphedema and dissected its mechanisms.

DOI: 10.1161/JAHA.113.000438
PubMed: 24052499


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:24052499

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Adiponectin-mediated modulation of lymphatic vessel formation and lymphedema.</title>
<author>
<name sortKey="Shimizu, Yuuki" sort="Shimizu, Yuuki" uniqKey="Shimizu Y" first="Yuuki" last="Shimizu">Yuuki Shimizu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya</wicri:regionArea>
<wicri:noRegion>Nagoya</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shibata, Rei" sort="Shibata, Rei" uniqKey="Shibata R" first="Rei" last="Shibata">Rei Shibata</name>
</author>
<author>
<name sortKey="Ishii, Masakazu" sort="Ishii, Masakazu" uniqKey="Ishii M" first="Masakazu" last="Ishii">Masakazu Ishii</name>
</author>
<author>
<name sortKey="Ohashi, Koji" sort="Ohashi, Koji" uniqKey="Ohashi K" first="Koji" last="Ohashi">Koji Ohashi</name>
</author>
<author>
<name sortKey="Kambara, Takahiro" sort="Kambara, Takahiro" uniqKey="Kambara T" first="Takahiro" last="Kambara">Takahiro Kambara</name>
</author>
<author>
<name sortKey="Uemura, Yusuke" sort="Uemura, Yusuke" uniqKey="Uemura Y" first="Yusuke" last="Uemura">Yusuke Uemura</name>
</author>
<author>
<name sortKey="Yuasa, Daisuke" sort="Yuasa, Daisuke" uniqKey="Yuasa D" first="Daisuke" last="Yuasa">Daisuke Yuasa</name>
</author>
<author>
<name sortKey="Kataoka, Yoshiyuki" sort="Kataoka, Yoshiyuki" uniqKey="Kataoka Y" first="Yoshiyuki" last="Kataoka">Yoshiyuki Kataoka</name>
</author>
<author>
<name sortKey="Kihara, Shinji" sort="Kihara, Shinji" uniqKey="Kihara S" first="Shinji" last="Kihara">Shinji Kihara</name>
</author>
<author>
<name sortKey="Murohara, Toyoaki" sort="Murohara, Toyoaki" uniqKey="Murohara T" first="Toyoaki" last="Murohara">Toyoaki Murohara</name>
</author>
<author>
<name sortKey="Ouchi, Noriyuki" sort="Ouchi, Noriyuki" uniqKey="Ouchi N" first="Noriyuki" last="Ouchi">Noriyuki Ouchi</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:24052499</idno>
<idno type="pmid">24052499</idno>
<idno type="doi">10.1161/JAHA.113.000438</idno>
<idno type="wicri:Area/PubMed/Corpus">001912</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001912</idno>
<idno type="wicri:Area/PubMed/Curation">001912</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001912</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001912</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001912</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Adiponectin-mediated modulation of lymphatic vessel formation and lymphedema.</title>
<author>
<name sortKey="Shimizu, Yuuki" sort="Shimizu, Yuuki" uniqKey="Shimizu Y" first="Yuuki" last="Shimizu">Yuuki Shimizu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya</wicri:regionArea>
<wicri:noRegion>Nagoya</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shibata, Rei" sort="Shibata, Rei" uniqKey="Shibata R" first="Rei" last="Shibata">Rei Shibata</name>
</author>
<author>
<name sortKey="Ishii, Masakazu" sort="Ishii, Masakazu" uniqKey="Ishii M" first="Masakazu" last="Ishii">Masakazu Ishii</name>
</author>
<author>
<name sortKey="Ohashi, Koji" sort="Ohashi, Koji" uniqKey="Ohashi K" first="Koji" last="Ohashi">Koji Ohashi</name>
</author>
<author>
<name sortKey="Kambara, Takahiro" sort="Kambara, Takahiro" uniqKey="Kambara T" first="Takahiro" last="Kambara">Takahiro Kambara</name>
</author>
<author>
<name sortKey="Uemura, Yusuke" sort="Uemura, Yusuke" uniqKey="Uemura Y" first="Yusuke" last="Uemura">Yusuke Uemura</name>
</author>
<author>
<name sortKey="Yuasa, Daisuke" sort="Yuasa, Daisuke" uniqKey="Yuasa D" first="Daisuke" last="Yuasa">Daisuke Yuasa</name>
</author>
<author>
<name sortKey="Kataoka, Yoshiyuki" sort="Kataoka, Yoshiyuki" uniqKey="Kataoka Y" first="Yoshiyuki" last="Kataoka">Yoshiyuki Kataoka</name>
</author>
<author>
<name sortKey="Kihara, Shinji" sort="Kihara, Shinji" uniqKey="Kihara S" first="Shinji" last="Kihara">Shinji Kihara</name>
</author>
<author>
<name sortKey="Murohara, Toyoaki" sort="Murohara, Toyoaki" uniqKey="Murohara T" first="Toyoaki" last="Murohara">Toyoaki Murohara</name>
</author>
<author>
<name sortKey="Ouchi, Noriyuki" sort="Ouchi, Noriyuki" uniqKey="Ouchi N" first="Noriyuki" last="Ouchi">Noriyuki Ouchi</name>
</author>
</analytic>
<series>
<title level="j">Journal of the American Heart Association</title>
<idno type="eISSN">2047-9980</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adiponectin (physiology)</term>
<term>Animals</term>
<term>Endothelial Cells (physiology)</term>
<term>Lymphangiogenesis</term>
<term>Lymphedema (etiology)</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Knockout</term>
<term>Nitric Oxide Synthase Type III (physiology)</term>
<term>Proto-Oncogene Proteins c-akt (physiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adiponectine (physiologie)</term>
<term>Animaux</term>
<term>Cellules endothéliales (physiologie)</term>
<term>Lymphangiogenèse</term>
<term>Lymphoedème (étiologie)</term>
<term>Mâle</term>
<term>Nitric oxide synthase type III (physiologie)</term>
<term>Protéines proto-oncogènes c-akt (physiologie)</term>
<term>Souris</term>
<term>Souris knockout</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Adiponectin</term>
<term>Nitric Oxide Synthase Type III</term>
<term>Proto-Oncogene Proteins c-akt</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Adiponectine</term>
<term>Cellules endothéliales</term>
<term>Nitric oxide synthase type III</term>
<term>Protéines proto-oncogènes c-akt</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Endothelial Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Lymphangiogenesis</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Knockout</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Lymphangiogenèse</term>
<term>Mâle</term>
<term>Souris</term>
<term>Souris knockout</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Obesity is linked with an increased risk of lymphedema, which is a serious clinical problem. Adiponectin is a circulating adipokine that is down-regulated in obese states. We investigated the effects of adiponectin on lymphatic vessel formation in a model of lymphedema and dissected its mechanisms.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24052499</PMID>
<DateCreated>
<Year>2013</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>01</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2047-9980</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>2</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2013</Year>
<Month>Sep</Month>
<Day>19</Day>
</PubDate>
</JournalIssue>
<Title>Journal of the American Heart Association</Title>
<ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation>
</Journal>
<ArticleTitle>Adiponectin-mediated modulation of lymphatic vessel formation and lymphedema.</ArticleTitle>
<Pagination>
<MedlinePgn>e000438</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.113.000438</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Obesity is linked with an increased risk of lymphedema, which is a serious clinical problem. Adiponectin is a circulating adipokine that is down-regulated in obese states. We investigated the effects of adiponectin on lymphatic vessel formation in a model of lymphedema and dissected its mechanisms.</AbstractText>
<AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">A mouse model of lymphedema was created via ablation of tail surface lymphatic network. Adiponectin-knockout mice showed the greater diameter of the injured tail compared with wild-type mice, which was associated with lower numbers of lymphatic endothelial cells (LECs). Systemic delivery of adiponectin reduced the thickness of the injured tail and enhanced LEC formation in wild-type and adiponectin-knockout mice. Adiponectin administration also improved the edema of injured tails in obese KKAy mice. Treatment with adiponectin protein stimulated the differentiation of human LECs into tubelike structures and increased LEC viability. Adiponectin treatment promoted the phosphorylation of AMP-activated protein kinase (AMPK), Akt, and endothelial nitric oxide synthase n LECs. Blockade of AMPK or Akt activity abolished adiponectin-stimulated increase in LEC differentiation and viability and endothelial nitric oxide synthase phosphorylation. Inhibition of AMPK activation also suppressed adiponectin-induced Akt phosphorylation in LECs. In contrast, inactivation of Akt signaling had no effects on adiponectin-mediated AMPK phosphorylation in LECs. Furthermore, adiponectin administration did not affect the thickening of the damaged tail in endothelial nitric oxide synthase-knockout mice.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Adiponectin can promote lymphatic vessel formation via activation of AMPK/Akt/endothelial nitric oxide synthase signaling within LECs, thereby leading to amelioration of lymphedema.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shimizu</LastName>
<ForeName>Yuuki</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shibata</LastName>
<ForeName>Rei</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ishii</LastName>
<ForeName>Masakazu</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ohashi</LastName>
<ForeName>Koji</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kambara</LastName>
<ForeName>Takahiro</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Uemura</LastName>
<ForeName>Yusuke</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yuasa</LastName>
<ForeName>Daisuke</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kataoka</LastName>
<ForeName>Yoshiyuki</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kihara</LastName>
<ForeName>Shinji</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Murohara</LastName>
<ForeName>Toyoaki</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ouchi</LastName>
<ForeName>Noriyuki</ForeName>
<Initials>N</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>09</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Am Heart Assoc</MedlineTA>
<NlmUniqueID>101580524</NlmUniqueID>
<ISSNLinking>2047-9980</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D052242">Adiponectin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.13.39</RegistryNumber>
<NameOfSubstance UI="D052250">Nitric Oxide Synthase Type III</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2002 Nov;8(11):1288-95</RefSource>
<PMID Version="1">12368907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2003 Mar;111(5):717-25</RefSource>
<PMID Version="1">12618526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2011 Feb;11(2):85-97</RefSource>
<PMID Version="1">21252989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2003 Jun;52(6):1355-63</RefSource>
<PMID Version="1">12765944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83</RefSource>
<PMID Version="1">10092513</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2012 Jan 2;287(1):408-17</RefSource>
<PMID Version="1">22081609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 2010 Oct 1;24(19):2115-26</RefSource>
<PMID Version="1">20889712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2011 Aug 19;109(5):486-91</RefSource>
<PMID Version="1">21778431</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Lipidol. 2003 Dec;14(6):561-6</RefSource>
<PMID Version="1">14624132</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast J. 2010 Jan-Feb;16(1):48-54</RefSource>
<PMID Version="1">19889169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg Oncol. 2002 Jul;9(6):543-9</RefSource>
<PMID Version="1">12095969</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 2005 Oct;37(10):1072-81</RefSource>
<PMID Version="1">16170315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Heart Assoc. 2012 Aug;1(4):e000877</RefSource>
<PMID Version="1">23130156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2004 Dec;10(12):1384-9</RefSource>
<PMID Version="1">15558058</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2008 Jan 15;117(2):216-23</RefSource>
<PMID Version="1">18158361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1999 Jun 10;399(6736):597-601</RefSource>
<PMID Version="1">10376602</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2003 Nov 7;278(45):45021-6</RefSource>
<PMID Version="1">12944390</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Med. 2002 Jul;8(7):731-7</RefSource>
<PMID Version="1">12068289</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12677-82</RefSource>
<PMID Version="1">11592985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2001 Aug;86(8):3815-9</RefSource>
<PMID Version="1">11502817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2008;6(3-4):123-37</RefSource>
<PMID Version="1">19093784</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 2007 Oct 15;110(8):1868-74</RefSource>
<PMID Version="1">17823909</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 1999 Jan 29;443(3):285-9</RefSource>
<PMID Version="1">10025949</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scand J Plast Reconstr Surg Hand Surg. 1992;26(2):223-7</RefSource>
<PMID Version="1">1411352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11658-63</RefSource>
<PMID Version="1">15289610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2012 May 31;366(22):2136-7</RefSource>
<PMID Version="1">22646649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2005 Apr 29;96(8):838-46</RefSource>
<PMID Version="1">15790954</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anat Rec. 1997 Aug;248(4):490-7</RefSource>
<PMID Version="1">9268139</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Cancer. 2006 Jul;6(7):521-34</RefSource>
<PMID Version="1">16794635</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2002 Jun 28;90(12):1243-50</RefSource>
<PMID Version="1">12089061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS Lett. 2008 May 14;582(11):1607-12</RefSource>
<PMID Version="1">18423403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2004 Mar 5;94(4):e27-31</RefSource>
<PMID Version="1">14752031</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes. 2007 May;56(5):1387-94</RefSource>
<PMID Version="1">17287464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Jan 9;279(2):1304-9</RefSource>
<PMID Version="1">14557259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2009 Jan 16;284(3):1718-24</RefSource>
<PMID Version="1">18990685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Atherosclerosis. 2006 Oct;188(2):384-90</RefSource>
<PMID Version="1">16321391</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Genet. 2005 Oct;37(10):1023-4</RefSource>
<PMID Version="1">16195715</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FEBS J. 2009 Oct;276(20):5738-46</RefSource>
<PMID Version="1">19754873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetologia. 2003 Apr;46(4):459-69</RefSource>
<PMID Version="1">12687327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ J. 2009 Apr;73(4):608-14</RefSource>
<PMID Version="1">19261992</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2009 Apr 1;69(7):2801-8</RefSource>
<PMID Version="1">19318557</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2010 Feb 19;140(4):460-76</RefSource>
<PMID Version="1">20178740</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Obes. 1988;12(4):321-33</RefSource>
<PMID Version="1">3198310</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 1998 Jun 1;101(11):2567-78</RefSource>
<PMID Version="1">9616228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hypertension. 2003 Sep;42(3):231-4</RefSource>
<PMID Version="1">12860835</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2004 Jul 2;279(27):28670-4</RefSource>
<PMID Version="1">15123726</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D052242" MajorTopicYN="N">Adiponectin</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D042583" MajorTopicYN="Y">Lymphangiogenesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052250" MajorTopicYN="N">Nitric Oxide Synthase Type III</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3835259</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AMPK</Keyword>
<Keyword MajorTopicYN="N">Akt</Keyword>
<Keyword MajorTopicYN="N">adiponectin</Keyword>
<Keyword MajorTopicYN="N">eNOS</Keyword>
<Keyword MajorTopicYN="N">lymphangiogenesis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24052499</ArticleId>
<ArticleId IdType="pii">jah3303</ArticleId>
<ArticleId IdType="doi">10.1161/JAHA.113.000438</ArticleId>
<ArticleId IdType="pmc">PMC3835259</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Ishii, Masakazu" sort="Ishii, Masakazu" uniqKey="Ishii M" first="Masakazu" last="Ishii">Masakazu Ishii</name>
<name sortKey="Kambara, Takahiro" sort="Kambara, Takahiro" uniqKey="Kambara T" first="Takahiro" last="Kambara">Takahiro Kambara</name>
<name sortKey="Kataoka, Yoshiyuki" sort="Kataoka, Yoshiyuki" uniqKey="Kataoka Y" first="Yoshiyuki" last="Kataoka">Yoshiyuki Kataoka</name>
<name sortKey="Kihara, Shinji" sort="Kihara, Shinji" uniqKey="Kihara S" first="Shinji" last="Kihara">Shinji Kihara</name>
<name sortKey="Murohara, Toyoaki" sort="Murohara, Toyoaki" uniqKey="Murohara T" first="Toyoaki" last="Murohara">Toyoaki Murohara</name>
<name sortKey="Ohashi, Koji" sort="Ohashi, Koji" uniqKey="Ohashi K" first="Koji" last="Ohashi">Koji Ohashi</name>
<name sortKey="Ouchi, Noriyuki" sort="Ouchi, Noriyuki" uniqKey="Ouchi N" first="Noriyuki" last="Ouchi">Noriyuki Ouchi</name>
<name sortKey="Shibata, Rei" sort="Shibata, Rei" uniqKey="Shibata R" first="Rei" last="Shibata">Rei Shibata</name>
<name sortKey="Uemura, Yusuke" sort="Uemura, Yusuke" uniqKey="Uemura Y" first="Yusuke" last="Uemura">Yusuke Uemura</name>
<name sortKey="Yuasa, Daisuke" sort="Yuasa, Daisuke" uniqKey="Yuasa D" first="Daisuke" last="Yuasa">Daisuke Yuasa</name>
</noCountry>
<country name="Japon">
<noRegion>
<name sortKey="Shimizu, Yuuki" sort="Shimizu, Yuuki" uniqKey="Shimizu Y" first="Yuuki" last="Shimizu">Yuuki Shimizu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C65 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001C65 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24052499
   |texte=   Adiponectin-mediated modulation of lymphatic vessel formation and lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:24052499" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024